Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129223) titled 'Mechanistic study of orlistat in ameliorating overweight/obesity through modulation of gut microbiota' on Aug. 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
Overweight and Obesity
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2024-09-04
Target Sample Size: Intervention group:69;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=314391
Published by HT Digital Content Services with permission from Health Daily Digest....